Literature DB >> 12970738

Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma.

R M'kacher1, A Bennaceur, F Farace, A Laugé, L F Plassa, E Wittmer, J Dossou, D Violot, E Deutsch, J Bourhis, D Stoppa-Lyonnet, V Ribrag, P Carde, C Parmentier, A Bernheim, A G Turhan.   

Abstract

Mantle cell lymphomas (MCL) are characterized by their aggressive behavior and poor response to chemotherapy regimens. We report here evidence of increased in vitro radiation sensitivity in two cell lines that we have generated from two MCL patients (UPN1 and UPN2). However, despite their increased radiation sensitivity, UPN2 cells were totally resistant to apoptotic cell death, whereas UPN1 cells underwent massive apoptosis 6 h after irradiation. The frequency of induced chromosomal abnormalities was higher in UPN1 as compared to UPN2. Distinct mechanisms have been found to contribute to this phenotype: a major telomere shortening (UPN1 and UPN2), deletion of one ATM allele and a point mutation in the remaining allele in UPN2, mutation of p53 gene (UPN1 and UPN2) with absence of functional p53 as revealed by functional yeast assays. After irradiation, Ku70 levels in UPN1 increased and decreased in UPN2, whereas in the same conditions, DNA-PKcs protein levels decreased in UPN1 and remained unchanged in UPN2. Thus, irradiation-induced apoptotic cell death can occur despite the nonfunctional status of p53 (UPN1), suggesting activation of a unique pathway in MCL cells for the induction of this event. Overall, our study demonstrates that MCL cells show increased radiation sensitivity, which can be the result of distinct molecular events. These findings could clinically be exploited to increase the dismal response rates of MCL patients to the current chemotherapy regimens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970738     DOI: 10.1038/sj.onc.1206826

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Targeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled anti-EGFR antibody.

Authors:  Hong Song; Mohammad Hedayati; Robert F Hobbs; Chunbo Shao; Frank Bruchertseifer; Alfred Morgenstern; Theodore L Deweese; George Sgouros
Journal:  Mol Cancer Ther       Date:  2013-07-19       Impact factor: 6.261

2.  Synergistic Effect and Tolerance of Concurrent Radiotherapy and Lenalidomide Use in Relapsing Mantle Cell Lymphoma: A Case Report.

Authors:  Mariem Bohli; Hager Jaffel; Gaiet El Fida Noubbigh; Sabrine Tbessi; Fehmi Msadek; Lotfi Kochbati
Journal:  Perm J       Date:  2020-11

3.  The genomics of lung adenocarcinoma: opportunities for targeted therapies.

Authors:  Heidi Greulich
Journal:  Genes Cancer       Date:  2010-12

4.  ATM deficiency sensitizes mantle cell lymphoma cells to poly(ADP-ribose) polymerase-1 inhibitors.

Authors:  Chris T Williamson; Huong Muzik; Ali G Turhan; Alberto Zamò; Mark J O'Connor; D Gwyn Bebb; Susan P Lees-Miller
Journal:  Mol Cancer Ther       Date:  2010-02-02       Impact factor: 6.261

5.  Measles virus entry through the signaling lymphocyte activation molecule governs efficacy of mantle cell lymphoma radiovirotherapy.

Authors:  Tanner S Miest; Marie Frenzke; Roberto Cattaneo
Journal:  Mol Ther       Date:  2013-08-05       Impact factor: 11.454

Review 6.  Current management of mantle cell lymphoma.

Authors:  Oliver Weigert; Michael Unterhalt; Wolfgang Hiddemann; Martin Dreyling
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53.

Authors:  Chris T Williamson; Eiji Kubota; Jeffrey D Hamill; Alexander Klimowicz; Ruiqiong Ye; Huong Muzik; Michelle Dean; LiRen Tu; David Gilley; Anthony M Magliocco; Bruce C McKay; D Gwyn Bebb; Susan P Lees-Miller
Journal:  EMBO Mol Med       Date:  2012-03-13       Impact factor: 12.137

8.  Peripheral blood complete remission after splenic irradiation in mantle-cell lymphoma with 11q22-23 deletion and ATM inactivation.

Authors:  Andrea Riccardo Filippi; Pierfrancesco Franco; Marco Galliano; Umberto Ricardi
Journal:  Radiat Oncol       Date:  2006-09-06       Impact factor: 3.481

Review 9.  Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives.

Authors:  Corina Cuceu; William M Hempel; Laure Sabatier; Jacques Bosq; Patrice Carde; Radhia M'kacher
Journal:  Cancers (Basel)       Date:  2018-03-26       Impact factor: 6.639

10.  Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability .

Authors:  Corina Cuceu; Bruno Colicchio; Eric Jeandidier; Steffen Junker; François Plassa; Grace Shim; Justyna Mika; Monika Frenzel; Mustafa Al Jawhari; William M Hempel; Grainne O'Brien; Aude Lenain; Luc Morat; Theodore Girinsky; Alain Dieterlen; Joanna Polanska; Christophe Badie; Patrice Carde; Radhia M'Kacher
Journal:  Cancers (Basel)       Date:  2018-07-13       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.